CoChat

Protocol for the PACE trial: A randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy

Open access
the PACE trial group, White, Peter D, Sharpe, Michael C, Chalder, Trudie, DeCesare, Julia C, Walwyn, Rebecca · 2007 · BMC Neurology
Cited by 145

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Chronic fatigue syndrome (CFS, also called myalgic encephalomyelitis /encephalopathy or ME) is a debilitating condition with no known cause or cure. Improvement may occur with medical care and additional therapies of pacing, cognitive behavioural therapy and graded exercise therapy. The latter two therapies have been found to be efficacious in small trials, but patient organisations surveys have reported adverse effects. Although pacing has been advocated by patient organisations, it lacks empirical support. Specialist medical care is commonly provided but its efficacy when given alone is not established. This trial compares the efficacy of the additional therapies when added to specialist medical care against specialist medical care alone. METHODS: 600 patients, who meet operationalised diagnostic criteria for CFS, will be recruited from secondary care into a randomised trial of four treatments, stratified by current co morbid depressive episode and different CFS/ME criteria. The four treatments are standardised specialist medical care either given alone, or with adaptive pacing therapy or cognitive behaviour therapy or graded exercise therapy. Supplementary therapies will involve fourteen sessions over 23 weeks and a booster session at 36 weeks. Outcome will be assessed at 12, 24, and 52 weeks after randomisation. Two primary outcomes of self-rated fatigue and physical function will assess differential effects of each treatment on these measures. Secondary outcomes include adverse events and reactions, subjective measures of symptoms, mood, sleep and function and objective measures of physical activity, fitness, cost-effectiveness and cost-utility. The primary analysis will be based on intention to treat and will use logistic regression models to compare treatments. Secondary outcomes will be analysed by repeated measures analysis of variance with a linear mixed model. All analyses will allow for stratification factors. Mediators and moderators will be explored using multiple linear and logistic regression techniques with interactive terms, with the sample split into two to allow validation of the initial models. Economic analyses will incorporate sensitivity measures. DISCUSSION: The results of the trial will provide information about the benefits and adverse effects of these treatments, their cost-effectiveness and cost-utility, the process of clinical improvement and the predictors of efficacy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2377-7-6

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 39

  1. Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, Evengard B, White PD, Nisenbaum R, Unger ER: The International Chronic Fatigue Syndrome Study Group Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Services Research. 2003, 3 (25): · DOI · Paper page
  2. Sharpe MC, Archard LC, Banatvala JE, al. : A report - chronic fatigue syndrome. J R Soc Med. 1991, 84: 118-121. · DOI · Paper page
  3. Interventions for the management of CFS/ME. Effective Health Care NHS Centre for Reviews and Dissemination. 2002, 7 (4): 1-12.
  4. Lloyd A, Pender H: The economic impact of chronic fatigue syndrome. Med J Australia. 1992, 157: 599-601. · DOI · Paper page
  5. Twemlow SW, Bradshaw SL Jr, Coyne L, Lerma BH: Patterns of utilization of medical care and perceptions of the relationship between doctor and patient with chronic illness including chronic fatigue syndrome. Psychol Rep. 1997, 80 (2): 643-658. · doi:10.2466/pr0.1997.80.2.643
  6. Joyce J, Hotopf M, Wessely S: The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. Q J Med. 1997, 90: 223-233. · DOI · Paper page
  7. Mulrow CD, Ramirez G, Cornell JE, Allsup K: Defining and Managing Chronic Fatigue Syndrome. Agency for Healthcare Research and Quality. 2001, Evidence Report/Technology Assessment No. 42. AHRQ Publication No. 02-E001. Rockville (MD):
  8. Action for M.E.: Severely neglected ME in the UK. 2001, London, Action for M.E.
  9. Cooper L. London: Action for M.E. and the ME association: Report on survey of members of local ME groups. 2000
  10. Action for M.E.: Membership Survey 'your experiences' questionnaire. 2003, Wells , Action for M.E
  11. Pesek JR, Jason LA, Taylor RR: An empirical investigation of the envelope theory. Journal of Human Behavior in the Social Environment. 2000, 3: 59-77. 10.1300/J137v03n01_04. · DOI
  12. Friedberg F, Krupp LB: A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression. Clinical Infectious Diseases. 1994, 18 (Suppl. 1): S105-S110. · DOI · Paper page
  13. McCrone P, Ridsdale L, Darbishire L, Seed P: Cost-effectiveness of cognitive behavioural therapy, graded exercise and usual care for patients with chronic fatigue in primary care. Psychological Medicine. 2004, 34: 1-9. 10.1017/S0033291703001351. · DOI · Paper page
  14. Ridsdale L, Godfrey E, Chalder T, Seed P, King M, Wallace T, et al: Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. Br J Gen Pract. 2001, 51: 19-24.
  15. Darbishire L, Ridsdale L, Seed PT: Distinguishing patients with chronic fatigue from those with chronic fatigue syndrome: a diagnostic study in UK primary care. British Journal of General Practice. 2003, 53 (491): 441-445.
  16. Fulcher KY, White PD: Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ. 1997, 314: 1647-1652. · DOI · Paper page
  17. Wearden A, Morriss R, Mullis R, et al: A double-blind, placebo controlled treatment trial of fluoxetine and a graded exercise programme for chronic fatigue syndrome. Br J Psychiatry. 1998, 172: 485-490. · DOI · Paper page
  18. Ware JE, C S: The MOS 36-item short form health survey (SF-36). Med Care. 1992, 30: 473-483. 10.1097/00005650-199206000-00002. · DOI · Paper page
  19. Royal Colleges: Chronic Fatigue Syndrome: Report of a joint working group of the Royal Colleges of Physicians, Psychiatrists and General Practitioners. 1996, Royal College of Physicians, 1-58.
  20. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/ PSY SCREEN). New York, Biometrics Research, New York State Psychiatric Institute, November 2002
  21. Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M: Effect of a self-management programme for patients with chronic disease. Effective Clinical Practice. 2001, 4: 256-262.
  22. Kroenke K, Spitzer RL, Williams JBW: The PHQ-15: Validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002, 64: 258-266. · DOI · Paper page
  23. Jenkins CD, Stanton B, Niemcryk S, Rose R: A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 1988, 41: 313-321. 10.1016/0895-4356(88)90138-2. · DOI · Paper page
  24. Zigmond A, R S: The hospital anxiety and depression scale. Act Psychiatr Scand. 1983, 87: 361-370. · DOI · Paper page
  25. Beecham J K, Knapp MRJ: Costing mental health interventions. In: Thornicroft G, Measuring Mental Health Needs. 2001, London , Gaskell
  26. Petrella RJ, Koval JJ, Cunningham DA, Paterson DH: A self-paced step test to predict aerobic fitness in older adults in the primary care clinic. J Am Geriatr Soc. 2001, 49: 632-638. 10.1046/j.1532-5415.2001.49124.x. · DOI · Paper page
  27. Borg G: Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970, 2: 92-98. · DOI · Paper page
  28. Burgess M, Chalder T: Telephone / postal cognitive behaviour therapy for chronic fatigue syndrome in secondary care: a pilot study. Behavioural and Cognitive Psychotherapy. 2001, 29: 447-455. 10.1017/S1352465801004052. · DOI
  29. Lloyd AR, Hickie I, Brockman A, Hickie C, Wilson A, Dwyer J, al. : Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med. 1993, 94: 197-203. 10.1016/0002-9343(93)90183-P. · DOI · Paper page
  30. Guy W: ECDEU Assessment Manual for Psychopharmacology. 1976, Rockville, MD, NIMH, 218-222.
  31. Ridsdale L, Darbishire L, Seed PT: Is graded exercise better than cognitive behaviour therapy for fatigue? A UK randomised trial in primary care. Psychol Med. 2004, 34: 37-49. 10.1017/S0033291703001247. · DOI · Paper page
  32. Jenkinson C, Coulter A, L W: Short form 36 (SF-36) Health Survey questionnaire: normative data from a large random sample of working age adults. BMJ. 1993, 306: 1437-1440. · DOI · Paper page
  33. Bowling A, Bond M, Jenkinson C, Lamping D: Short form 36 (SF-36) health survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus Survey in Britain, The Health Survey for England and the Oxford Healthy Life Survey. J Publ Health Med. 1999, 21: 255-270. 10.1093/pubmed/21.3.255. · DOI · Paper page
  34. Godfrey E, Chalder T, Ogden J, Ridsdale L: The development of a measure to assess process in cognitive behavioural psychotherapy and counselling. British Journal of Clinical Psychology.
  35. Netten A, Curtis L: Unit Costs of Health and Social Care 2003. 2003, Canterbury, Personal Social Services Research Unit
  36. Lilford RJ, Jackson J: Equipoise and the ethics of randomisation. J Roy Soc Med. 1995, 88: 552-559.
  37. White PD, Naish VAB: Graded exercise therapy for chronic fatigue syndrome: An audit. Physiotherapy. 2001, 87: 285-288. 10.1016/S0031-9406(05)60762-6. · DOI
  38. Machin D, Campbell MJ, Fayers PM, Pinol APY: Sample Size Tables for Clinical Studies. 1997, Blackwell Science. , 2nd edn. :
  39. Hollis S: A graphical sensitivity analysis for clinical trials with non-ignorable missing binary outcomes. Statistics in Medicine. 2002, 21: 3823-3834. 10.1002/sim.1276. · DOI

Cited by

See all 145

Metadata

Authors
the PACE trial group, White, P. D., Sharpe, M. C., Chalder, T., DeCesare, J. C., & Walwyn, R.
Venue
BMC Neurology
Published
2007-03-08
Volume
7
Issue
1
Pages
6-6
ISSN
1471-2377 (ISSN-L)
OpenAlex
W1981138990
Cited by
145
References
16
FWCI
3.46
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protocol for the PACE trial: A randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy. https://app.cochat.ai/papers/10.1186/1471-2377-7-6
The paper
the PACE trial group, White, P. D., Sharpe, M. C., Chalder, T., DeCesare, J. C., & Walwyn, R. (2007). Protocol for the PACE trial: A randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy. BMC Neurology. https://doi.org/10.1186/1471-2377-7-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.